Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and patient education are crucial for managing alopecia areata.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

People with alopecia areata in German-speaking countries spend a lot on their condition, with hair products and treatments being the most costly.

Stress can cause temporary hair loss, which usually gets better after the stress is gone.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Minoxidil is effective in treating various types of hair loss and can improve quality of life, with combination therapies showing increased effectiveness.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

The review found that specific changes in scalp tissue can help diagnose different types of hair loss.

A new hair loss treatment combining minoxidil and cedrol improves hair growth and reduces side effects.

High mTORC1 activity slows hair growth and causes it to lose color.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

High levels of the seizure medication sodium valproate can cause hair loss.

Good nutrition may help prevent premature hair graying.

Valproic acid treatment may cause temporary hair loss due to reduced zinc and biotinidase levels, which tend to normalize after 6 months.

Korean Red Ginseng may protect against hair loss caused by chemotherapy.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Scalp tonics are popular for stress-related hair loss, but minoxidil is used less due to side effects and inconvenience.

Dermoscopy helps distinguish between scarring and non-scarring hair loss and accurately diagnoses hair and scalp conditions without needing hair plucking.